Clinical evaluation of felodipine in hypertensive patients previously treated with a triple drug regimen.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D015736:Felodipine; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use; D006852:Hydrochlorothiazide / Q000627:therapeutic use; D006973:Hypertension / Q000188:drug therapy*; D009568:Nitrendipine / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D006852:Hydrochlorothiazide; D006830:Hydralazine; D009568:Nitrendipine; D015736:Felodipine